USE OF A2A ADENOSINE RECEPTOR AGONISTS

摘要

Myocardial imaging methods that are accomplished by administering doses of a pharmaceutical composition including regadenoson - an adenosine A_2A receptor agonist - to a human undergoing myocardial imaging in an amount sufficient to achieve at least a minimal increase in average coronary peak flow velocity.